Standard precautions: what is meant and what is not

E.T. Curran^*
*NHS National Services Scotland, Health Protection Scotland, UK
Journal of Hospital Infection (2015) 90, 10-11
No abstract.
サマリー原文（英語）はこちら
監訳者コメント：
英国ではカルバペネム分解酵素産生菌の感染対策にからみ、標準予防策とは何かの記載について、WHO と CDC、スコットランド地方の保健当局ならびに英国のエビデンスに基づく感染予防ガイドライン（epic3 プロジェクト）との間で食い違いがあり混乱を招いていると指摘、概念の統一性と今後の進歩に期待を寄せている。

Association between infection prevention and control staffing levels and healthcare-associated infection prevalence: results from the 2022 Belgian European Centre for Disease Prevention and Control point prevalence survey

A. Bruyneel*, K. Latour, M. Pearcy, B. Byl, N. Houdart, A. Simon, L. Catteau
*Université Libre de Bruxelles (ULB), Belgium

Journal of Hospital Infection (2026) 172, 18-26

Infection prevention and control practices in hospitals across Pakistan: a nationwide assessment using the WHO infection prevention and control assessment framework

Z.U. Mustafa*, M.S. Bashir, Y. Nawal, R. Ahmad, M. Salman, F. Naeem, R. Rizwan, M. Arshed, S. Mudenda, N. Aslam, S. Khan, K. Alam, N. Kumar, S. Ali, I.A. Safeh, C.E. Moore, B. Godman, J.C. Meyer
*Riphah International University, Pakistan

Journal of Hospital Infection (2026) 174, 254-273

Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach
E. Tchouaket Nguemeleu^*, I. Beogo, D. Sia, K. Kilpatrick, C. Séguin, A. Baillot , M. Jabbour, N. Parisien, S. Robins, S. Boivin
^*Université Du Québec en Outaouais, Canada
Journal of Hospital Infection (2020) 106, 134-154

Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital

Epidemiology of infection and current guidelines for infection prevention in cystic fibrosis patients